Skip to content
← Full study record

NCT00861705 · MORE INFO

Limitations, agreements, and source contact

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery · Source last updated 2026-06-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
wsikov@lifespan.org
organization
Warren Alpert Medical School of Brown University, Department of Medicine
phone
401-793-7151
title
William M. Sikov, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
wsikov@lifespan.org
organization
Warren Alpert Medical School of Brown University, Department of Medicine
phone
401-793-7151
title
William M. Sikov, M.D.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice